0001104659-24-002651.txt : 20240109
0001104659-24-002651.hdr.sgml : 20240109
20240109180501
ACCESSION NUMBER: 0001104659-24-002651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIBBS KATHY L
CENTRAL INDEX KEY: 0001267487
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34180
FILM NUMBER: 24524376
MAIL ADDRESS:
STREET 1: C/O VIROLOGIC
STREET 2: 345 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC.
CENTRAL INDEX KEY: 0001162194
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 770513190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 TOWER PLACE
STREET 2: SUITE 2000
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502666000
MAIL ADDRESS:
STREET 1: 2 TOWER PLACE
STREET 2: SUITE 2000
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLUIDIGM CORP
DATE OF NAME CHANGE: 20011113
4
1
tm242400d4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-05
0
0001162194
STANDARD BIOTOOLS INC.
LAB
0001267487
HIBBS KATHY L
C/O STANDARD BIOTOOLS INC.
2 TOWER PLACE, STE 2000
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Common Stock
2024-01-05
4
A
0
79412
0
A
79412
D
Stock Option (Right to buy)
2.47
2024-01-05
4
A
0
205794
A
2033-06-07
Common Stock
205794
205794
D
Represents Restricted Stock Units ("RSUs") that vest in four equal annual installments beginning January 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
25% of the shares underlying the option vest on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is fully vested, subject to the Reporting Person's continued service through the applicable vesting date.
Pursuant to the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc. (the "Company"), Martis Merger Sub, Inc. and SomaLogic, Inc. ("Soma Logic") (the "Merger"), each option to purchase SomaLogic common stock (a "SomaLogic Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time"), was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 (the "Exchange Ratio") rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent.
Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time.
/s/ Agnieszka Gallagher, Attorney-in-Fact
2024-01-09